Evidence map›Paper›PMID 35018505›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2022

Cochlear implant in vestibular schwannomas: long-term outcomes and critical analysis of indications.

Flavia Sorrentino, Giulia Tealdo, Diego Cazzador, Niccolò Favaretto, Davide Brotto, Silvia Montino, Ezio Caserta, Roberto Bovo, Luca Denaro, Valentina Baro and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Flavia Sorrentino *Section of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
Giulia Tealdo *Section of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
Diego Cazzador *Section of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy. diego.cazzador@unipd.it.ORCID http://orcid.org/0000-0001-7272-7469
Niccolò FavarettoSection of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
Davide BrottoSection of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
Silvia MontinoSection of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
Ezio CasertaSection of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
Roberto BovoSection of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
Luca DenaroSection of Neurosurgery, Department of Neurosciences, University of Padova, Padua, Italy.
Valentina BaroSection of Neurosurgery, Department of Neurosciences, University of Padova, Padua, Italy.
Domenico D'AvellaSection of Neurosurgery, Department of Neurosciences, University of Padova, Padua, Italy.
Alessandro MartiniSection of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
Antonio MazzoniSection of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
Gino MarioniSection of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
Elisabetta ZanolettiSection of Otolaryngology, Otolaryngology Unit, Department of Neurosciences, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe our institutional experience in cochlear implantation after vestibular schwannoma (VS) resection, and compare the audiological outcomes between sporadic and neurofibromatosis type 2 (NF2) VS sub-cohorts of patients, and in relation to preoperative contralateral hearing.

methodsSeventeen patients (8 sporadic and 9 NF2-associated VSs) who had undergone VS resection and cochlear implant (CI) were analyzed retrospectively. Audiological outcomes at 24 months were correlated with preoperative clinical variables. The results according to VS type (sporadic vs. NF2-associated) and contralateral hearing (impaired vs. normal) were compared.

resultsFourteen CIs were actively used by the patients (77.8%). Twenty-four months after CI activation, the median postoperative PTA (pure tone average) was 45.6 dB nHL and a measurable WRS (Word Recognition Score) was achieved by 44.4% of patients (median WRS = 40%). The median postoperative PTA in the implanted ear resulted better in the group with an impaired contralateral hearing (36.3 dB nHL vs. 78.8 dB nHL, p = 0.019). Good preoperative contralateral hearing status (A-B classes of AAO-HNS) was a negative prognostic factor for CI performance on open-set discrimination (OR = 28.0, 95% CI 2.07-379.25, p = 0.012).

conclusionsCI is a viable rehabilitative option for patients with sporadic or NF2-associated VS. A good contralateral hearing adversely affects CI outcome and should be taken into consideration for patients' selection and rehabilitation programs.

Indexed as

Cochlear ImplantationCochlear ImplantsNeuroma, AcousticHearing LossHumansNeurofibromatosis 2Retrospective StudiesTreatment OutcomeCochlear implantHearing rehabilitationNeurofibromatosis type 2SporadicVestibular schwannoma

Identifiers

PMID35018505
OpenAlexW4205657090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.